Elevated levels of G-CSF have been found in the CSF of patients with neuromyelitis optica compared with patients with other neurological non-inflammatory conditions [46], and it has also been reported that treatment with G-CSF may promote clinical worsening in patients with MS [47]. This evidence concerns the gene CSF3 and neuromyelitis optica.